S Katari1, M A Wood-Trageser1, H Jiang1, E Kalynchuk1, R Muzumdar1, S A Yatsenko1, A Rajkovic1. 1. Department of Obstetrics, Gynecology, and Reproductive Sciences (S.K., M.A.W.-T., H.J., S.A.Y., A.R.), Magee-Women's Research Institute, Pittsburgh, Pennsylvania 15213; Department of Pathology (A.R.), University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213; Department of Endocrinology (R.M.), Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15224; and Department of Human Genetics (E.K., S.A.Y., A.R.), University of Pittsburgh, Pittsburgh, Pennsylvania 15261.
Abstract
CONTEXT: Inactivating FSH receptor (FSHR) mutations can affect ovarian function, resulting in variable clinical presentations ranging from primary amenorrhea to premature menopause. FSHR mutations have been largely reported in the Finnish population, but in patients of Asian Indian descent, the incidence of FSHR mutations is extremely rare. CASE DESCRIPTION: Two female siblings of Indian descent were diagnosed with primary ovarian failure and hypergonadotropic hypogonadism. The daughters were the result of a consanguineous marriage between second cousins. A combination of comparative genomic hybridization plus single nucleotide polymorphism array and whole exome sequencing was conducted on the family to identify potential causative genetic variants. CONCLUSION: Both daughters were found to have a novel pathogenic variant in FSHR (c.1253T>G, p.Ile418Ser), inherited as an autosomal recessive trait from heterozygous parents. This loss of function mutation is located in exon 10 of FSHR affecting the second transmembrane helix of the FSHR protein. The transmembrane domain of FSHR is highly conserved across species and is involved in signal transduction. The FSHR c.1253T>G variant is next to a known pathogenic variant, rs12190966 (c.1255G>A, p.Ala419Thr), previously reported in a Finnish woman with primary amenorrhea.
CONTEXT: Inactivating FSH receptor (FSHR) mutations can affect ovarian function, resulting in variable clinical presentations ranging from primary amenorrhea to premature menopause. FSHR mutations have been largely reported in the Finnish population, but in patients of Asian Indian descent, the incidence of FSHR mutations is extremely rare. CASE DESCRIPTION: Two female siblings of Indian descent were diagnosed with primary ovarian failure and hypergonadotropic hypogonadism. The daughters were the result of a consanguineous marriage between second cousins. A combination of comparative genomic hybridization plus single nucleotide polymorphism array and whole exome sequencing was conducted on the family to identify potential causative genetic variants. CONCLUSION: Both daughters were found to have a novel pathogenic variant in FSHR (c.1253T>G, p.Ile418Ser), inherited as an autosomal recessive trait from heterozygous parents. This loss of function mutation is located in exon 10 of FSHR affecting the second transmembrane helix of the FSHR protein. The transmembrane domain of FSHR is highly conserved across species and is involved in signal transduction. The FSHR c.1253T>G variant is next to a known pathogenic variant, rs12190966 (c.1255G>A, p.Ala419Thr), previously reported in a Finnish woman with primary amenorrhea.
Authors: Swapna S Desai; Swati K Achrekar; Krupa A Sahasrabuddhe; Parvin K Meharji; Sadhana K Desai; Vijay S Mangoli; Smita D Mahale Journal: J Clin Endocrinol Metab Date: 2015-01-12 Impact factor: 5.958
Authors: Saleh AlAsiri; Sulman Basit; Michelle A Wood-Trageser; Svetlana A Yatsenko; Elizabeth P Jeffries; Urvashi Surti; Deborah M Ketterer; Sibtain Afzal; Khushnooda Ramzan; Muhammad Faiyaz-Ul Haque; Huaiyang Jiang; Michael A Trakselis; Aleksandar Rajkovic Journal: J Clin Invest Date: 2014-12-01 Impact factor: 14.808
Authors: Jau Ren Mao; Glen Taylor; Willow B Dean; Diane R Wagner; Veena Afzal; Jeffrey C Lotz; Edward M Rubin; James Bristow Journal: Nat Genet Date: 2002-03-04 Impact factor: 38.330
Authors: K Aittomäki; J L Lucena; P Pakarinen; P Sistonen; J Tapanainen; J Gromoll; R Kaskikari; E M Sankila; H Lehväslaiho; A R Engel; E Nieschlag; I Huhtaniemi; A de la Chapelle Journal: Cell Date: 1995-09-22 Impact factor: 41.582
Authors: M Jiang; K Aittomäki; C Nilsson; P Pakarinen; A Iitiä; T Torresani; H Simonsen; V Goh; K Pettersson; A de la Chapelle; I Huhtaniemi Journal: J Clin Endocrinol Metab Date: 1998-12 Impact factor: 5.958
Authors: I Beau; P Touraine; G Meduri; A Gougeon; A Desroches; C Matuchansky; E Milgrom; F Kuttenn; M Misrahi Journal: J Clin Invest Date: 1998-10-01 Impact factor: 14.808
Authors: Matthew S Bramble; Ellen H Goldstein; Allen Lipson; Tuck Ngun; Ascia Eskin; Jason E Gosschalk; Lara Roach; Neerja Vashist; Hayk Barseghyan; Eric Lee; Valerie A Arboleda; Daniel Vaiman; Zafer Yuksel; Marc Fellous; Eric Vilain Journal: Hum Reprod Date: 2016-02-23 Impact factor: 6.918
Authors: Ho Long Le; Vu Ngoc Anh Ho; Tam Thi Ngan Le; Van Thi Thu Tran; Mai Pham Que Ma; Anh Hoang Le; Linh Khanh Nguyen; Tuong Manh Ho; Lan Ngoc Vuong Journal: J Assist Reprod Genet Date: 2021-11-30 Impact factor: 3.412
Authors: Bushra Gorsi; Edgar Hernandez; Marvin Barry Moore; Mika Moriwaki; Clement Y Chow; Emily Coelho; Elaine Taylor; Claire Lu; Amanda Walker; Philippe Touraine; Lawrence M Nelson; Amber R Cooper; Elaine R Mardis; Aleksander Rajkovic; Mark Yandell; Corrine K Welt Journal: J Clin Endocrinol Metab Date: 2022-02-17 Impact factor: 5.958
Authors: Abdulmoein Eid Al-Agha; Ihab Abdulhamed Ahmed; Esther Nuebel; Mika Moriwaki; Barry Moore; Katherine A Peacock; Tim Mosbruger; Deborah W Neklason; Lynn B Jorde; Mark Yandell; Corrine K Welt Journal: J Clin Endocrinol Metab Date: 2018-02-01 Impact factor: 5.958
Authors: Sarah Eskenazi; Anne Bachelot; Justine Hugon-Rodin; Genevieve Plu-Bureau; Anne Gompel; Sophie Catteau-Jonard; Denise Molina-Gomes; Didier Dewailly; Catherine Dodé; Sophie Christin-Maitre; Philippe Touraine Journal: J Endocr Soc Date: 2021-03-01
Authors: Asma Sassi; Julie Désir; Véronique Janssens; Martina Marangoni; Dorien Daneels; Alexander Gheldof; Maryse Bonduelle; Sonia Van Dooren; Sabine Costagliola; Anne Delbaere Journal: F S Rep Date: 2020-08-22